The field of brain-computer interfaces is moving away from mind-controlled computer cursors to restoring speech.

Much more of this is necessary if the arsenal of democracy is not to depend on a handful of American firms. U kunt ons met ...

High-dose dazucorilant showed significant survival benefit in a Phase 2 ALS trial. It reduced mortality risk by up to 87% over two years for ALS patients. A pivotal Phase 3 trial for this ALS therapy ...

Masitinib treatment for ALS led to 42% of patients in a clinical trial surviving five years, nearly double historical rates, ...

A novel detection algorithm spotted moderate-to-severe aortic stenosis (AS) with a sensitivity of 90.5% of all patients and ...

Casey Ross and Bob Herman’s reporting exposes how UnitedHealth Group used an unregulated algorithm to override clinicians’ judgment and deny care to seriously ill older and disabled patients. The ...

After two years of treatment, there was an 87% reduction in death in treated patients compared with those who received ...

Rosa Rademakers and Bryan Traynor received this year’s Breakthrough Prize for identifying the most common genetic cause of two incurable neurodegenerative diseases.

Pandemic and epidemic intelligence integrates surveillance data with contextual knowledge to assess health risks and inform public health decisions. Although investments in surveillance and public ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story: While bones can regrow themselves ...